ArticleCirculation. Heart failure2022

Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis.

E Wilson Grandin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.